Soiken Holdings Inc. Logo

Soiken Holdings Inc.

A bioscience group offering clinical testing, supplements, and cosmetics for pharma/food industries.

2385 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
豊中市新千里東町一丁目4番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Soiken Holdings Inc. is a biotechnology group focused on health and bioscience, with a core business in the research and development of biomarkers and bioassay systems. The company provides clinical evaluation and testing services for the pharmaceutical and food industries. Through its subsidiaries, Soiken Holdings leverages its R&D capabilities to commercialize a range of products. These include unique dietary supplements, such as Imidapeptide, developed from industry-academia collaborations, and high-functionality cosmetics. The group is also engaged in the research, development, and sale of functional materials, provides marketing research for health products, and pursues advanced R&D in areas like gene therapy through strategic joint ventures.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 04:08
Regulatory News Service
確認書
Japanese 8.1 KB
2025-09-24 04:07
Annual Report
有価証券報告書-第31期(2024/07/01-2025/06/30)
Japanese 974.6 KB
2025-02-13 01:47
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-02-13 01:46
Interim Report
半期報告書-第31期(2024/07/01-2025/06/30)
Japanese 182.4 KB
2024-10-01 02:49
Regulatory News Service
臨時報告書
Japanese 23.6 KB
2024-09-27 03:11
Governance Information
内部統制報告書-第30期(2023/07/01-2024/06/30)
Japanese 22.6 KB
2024-09-27 03:09
Registration Form
確認書
Japanese 8.1 KB
2024-09-27 03:08
Annual Report
有価証券報告書-第30期(2023/07/01-2024/06/30)
Japanese 944.6 KB
2024-05-14 02:44
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-05-14 02:42
Quarterly Report
四半期報告書-第30期第3四半期(2024/01/01-2024/03/31)
Japanese 154.3 KB
2024-02-14 01:35
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-02-14 01:34
Quarterly Report
四半期報告書-第30期第2四半期(2023/10/01-2023/12/31)
Japanese 183.0 KB
2023-11-13 01:54
Report Publication Announcement
確認書
Japanese 8.1 KB
2023-11-13 01:53
Quarterly Report
四半期報告書-第30期第1四半期(2023/07/01-2023/09/30)
Japanese 153.0 KB
2023-10-02 03:23
Post-Annual General Meeting Information
臨時報告書
Japanese 22.2 KB

Automate Your Workflow. Get a real-time feed of all Soiken Holdings Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Soiken Holdings Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766

Talk to a Data Expert

Have a question? We'll get back to you promptly.